CSF1R and pancreatic neoplasm: Therefore, the inhibition of CSF-1R in vivo demonstrated a decrease in pancreatic tumor-initiating cells and improved chemotherapy efficacy [80], and the interruption CSF-1/CSF-1R signaling eliminated CD206hi TAMs within pancreatic tumors, reprogramming the remaining macrophages to support antitumor immunity [167].